Hormone-Refractory Prostate Cancer Terminated Phase 2 Trials for Itraconazole (DB01167)

Also known as: Hormone Refractory Prostate Cancer Disease / Hormone Refractory Prostate Cancer / Castration-resistant prostate cancer / Hormone refractory prostate cancer (disorder)

IndicationStatusPhase
DBCOND0030169 (Hormone-Refractory Prostate Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01450683Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapyTreatment